Indovinya, the global specialty chemical and surfactants division of Indorama Ventures, is pleased to announce the expansion of its strategic partnership with Quadra Chemicals, authorizing Quadra to promote and sell Indovinya’ s OXIPURITY® excipient-grade polyethylene glycol (PEG), polysorbate, and PG USP products throughout the North American pharmaceutical market.
This expanded agreement strengthens the collaboration between the two companies and enhances access to Indovinya’ s pharmaceutical-grade excipient portfolio for customers across the United States and Canada. Through Quadra’s established commercial organization, technical expertise, and deep relationships within the pharmaceutical industry, customers will benefit from improved access to reliable supply, regulatory support, and product application expertise.
The OXIPURITY® excipient portfolio includes high-purity PEGs, polysorbates, and PG USP (propylene glycol USP) products manufactured to meet the stringent quality, consistency, and regulatory requirements demanded by pharmaceutical and biopharmaceutical applications. These products are widely used in oral, topical, parenteral, and specialty drug formulations where performance, purity, and supply security are critical.
The expanded partnership reflects both companies’ commitment to developing & supporting pharmaceutical manufacturers with trusted ingredients and technical solutions that help accelerate innovation and improve patient outcomes.
“We are excited to expand our relationship with Quadra Chemicals and further strengthen our presence within the North American pharmaceutical market,” said Marco Hopf, North American Commercial Director, Indovinya. “Quadra’s business unit vertical model has demonstrated outstanding market knowledge, technical capabilities, and a strong commitment to customer success. Their robust supply chain capabilities will help serve customers and strengthen our presence in the pharmaceutical market. By extending their authorization to represent our OXIPURITY® excipient portfolio of PEG and polysorbate products, we are combining Indovinya’ s integrated, world-class manufacturing and quality standards with Quadra’s exceptional commercial reach and customer support. Together, we are well positioned to deliver greater value, supply reliability, and technical expertise to pharmaceutical customers across North America.”
From Quadra’s perspective, the expanded agreement represents the next phase of collaboration with Indovinya. Christine Infilise, Senior Vice-President, Ingredients & Corporate Marketing at Quadra, commented:
“We are excited to expand our longstanding partnership with Indovinya into the pharmaceutical market across Canada and the United States. Over many years, our organizations have built a strong and successful relationship founded on shared values, technical expertise, and a commitment to customer success. By adding Indovinya’s OXIPURITY®- high-purity pharmaceutical-grade PEGs, polysorbates and PG to our portfolio, we are strengthening our ability to deliver high-quality excipient solutions and trusted supply chain support to pharmaceutical manufacturers throughout North America. This expansion is a natural evolution of a partnership that has consistently created value for both organizations, and we look forward to accelerating growth together in the pharmaceutical sector.”
About Indorama Ventures
Indorama Ventures PCL, listed in Thailand (Bloomberg: IVL.TB), is one of the world’s leading sustainable petrochemicals producers, with a manufacturing footprint serving local and regional customers across Europe, Africa, the Americas, and the Asia Pacific. Our ~25,000 employees reimagine chemistry to create safe, responsible materials that sustain life-critical industries and improve the lives of billions of people. Our segments—Combined PET, Fibers, Indovinya, and Indovida—produce indispensable chemistry serving essential markets, including food & beverages, textiles, pharmaceuticals, home & personal care, automotive, and agrochemicals. The company’s diverse businesses generated revenue of $13.6 billion in 2025. Indorama Ventures is listed in the Dow Jones Best-In-Class Indices, recognizing our ambition to lead change and shape a future in which materials are more innovative and circular.
PRESS CONTACT: press.indovinya@indorama.net
About Quadra Chemicals
Quadra is a North American chemical and ingredient distribution powerhouse. We partner with the world’s best suppliers to provide an extensive and innovative product portfolio. Our people set us apart from the rest, offering specialized services and dedicated teams committed to delivering your tailored solutions.
